Sagimet Biosciences Inc. (NASDAQ:SGMT) has 87 institutional investors with active 13F positions as of March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,098,919 | 1,098,919 | 0.00% | $5,741,852.00 |
| Woodline Partners LP | 31 Mar, 2026 | 1,000,943 | 0 | 0.00% | $5,229,927.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 966,253 | 185,807 | 23.81% | $5,043,840.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 952,996 | 0 | 0.00% | $4,979,404.00 |
| Affinity Asset Advisors, LLC | 31 Mar, 2026 | 868,020 | -280,225 | -24.40% | $4,535,405.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 862,303 | 275,356 | 46.91% | $4,505,533.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 799,943 | -14,010 | -1.72% | $4,179,702.00 |
| HHLR ADVISORS, LTD. | 31 Mar, 2026 | 724,800 | 0 | 0.00% | $3,787,080.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 625,469 | 282,969 | 82.62% | $3,268,076.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 411,570 | -73,926 | -15.23% | $2,150,453.00 |
| Blue Owl Capital Holdings LP | 31 Mar, 2026 | 333,877 | -2,153,877 | -86.58% | $1,744,507.00 |
| Raymond James Financial Inc | 31 Mar, 2026 | 317,550 | 31,300 | 10.93% | $1,659,199.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 309,522 | 13,666 | 4.62% | $1,618,055.00 |
| Hudson Bay Capital Management LP | 31 Mar, 2026 | 303,223 | -1,249 | -0.41% | $1,584,340.00 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 299,641 | 0 | 0.00% | $1,565,624.00 |
| UBS Group AG | 31 Mar, 2026 | 293,934 | 92,175 | 45.69% | $1,535,806.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 271,217 | 135,178 | 99.37% | $1,414,594.00 |
| Pale Fire Capital SE | 31 Mar, 2026 | 221,875 | 0 | 0.00% | $1,159,297.00 |
| Point72 Asset Management, L.P. | 31 Mar, 2026 | 187,564 | 11,734 | 6.67% | $980,022.00 |
| Qube Research & Technologies Ltd | 31 Mar, 2026 | 182,738 | 71,389 | 64.11% | $954,806.00 |